Work

OAB-039: Treatment duration and long-term outcomes with daratumumab in transplant-ineligible newly diagnosed multiple myeloma from the phase 3 MAIA study

Year: 2022

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00312-3

Authors: Philippe Moreau, Thierry Facon, Saad Usmani, Shaji Kumar, Torben Plesner, Hartmut Goldschmidt, Robert Orlowski, Aurore Perrot, Ajai Chari, Gordon Cook, Huiling Pei, Rian Van Rampelbergh, J Blake Bartlett, Clarissa Uhlar, Robin Carson, Nizar Bahlis

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293086720

Cites:

Cited by: 2

Related to: 10